Founded in 2002, Hart Biologicals Ltd is based in Hartlepool in the North East of England. The Hartlepool facility is engaged in the research, development, manufacture, and marketing of a range of "in-vitro" diagnostic products for use in the detection, prevention, and monitoring of a number of medical conditions related to haemostasis and platelet function. Hart Biologicals’ products are based upon whole blood or blood plasma clotting technology or whole blood and platelet rich plasma aggregation and platelet function test principles—technologies that are available in almost all pathology laboratories worldwide. Hart Biologicals’ expertise, robust quality system, solid infrastructure, dedicated staff, and state-of-the-art manufacturing facilities have attracted partners ranging from small start-up companies and universities to large multi-national corporations. As a small company, Hart Biologicals can respond quickly to the needs of our partners and dedicate the best minds to their projects. Hart Biologicals provides contract services including Product Development, Regulatory Submission, Manufacturing, Customer Service, Sales, Marketing, and Global Product Distribution. Hart Biologicals is committed, through the company’s vision and capabilities, to providing innovative and quality medical products to meet the needs of an ever-changing healthcare field within a highly regulated environment.